ELI LILLY & Co R&D Expense 2007-2023 | LLY
Beta
What is r&d expense?
Research and development expense represents the costs incurred in discovering and developing new products, processes, or technologies.
What is ELI LILLY & Co's current r&d expense?
ELI LILLY & Co (LLY) annual r&d expense for 2022 was $7.19B, a 3.75% increase from 2021. ELI LILLY & Co r&d expense for the quarter ending June 30, 2023 was $2.36B.
What was ELI LILLY & Co's r&d expense in 2021?
ELI LILLY & Co annual r&d expense for 2021 was $6.93B, a 15.97% increase from 2020.
What was ELI LILLY & Co's r&d expense in 2020?
ELI LILLY & Co annual r&d expense for 2020 was $5.98B, a 6.82% increase from 2019.
What is ELI LILLY & Co's 5-year r&d expense CAGR?
ELI LILLY & Co r&d expense grew at a compound annual growth rate (CAGR) of 7.13% from FY2017 to FY2022, going from $5.10B to $7.19B over 5 years.
R&D Expense History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+7.1%
FY2017
$5.10B
→
FY2022
$7.19B
07080910111213141516171819202122
5 years selected
R&D Expense History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2022 | $7.19B | +3.8% | 10-K |
| FY2021 | $6.93B | +16.0% | 10-K |
| FY2020 | $5.98B | +6.8% | 10-K |
| FY2019 | $5.59B | +10.8% | 10-K |
| FY2018 | $5.05B | -0.9% | 10-K |
| FY2017 | $5.10B | -4.0% | 10-K |
| FY2016 | $5.31B | +10.7% | 10-K |
| FY2015 | $4.80B | +1.3% | 10-K |
| FY2014 | $4.73B | -14.4% | 10-K |
| FY2013 | $5.53B | +4.8% | 10-K |
| FY2012 | $5.28B | +5.1% | 10-K |
| FY2011 | $5.02B | +2.8% | 10-K |
| FY2010 | $4.88B | +12.9% | 10-K |
| FY2009 | $4.33B | +12.6% | 10-K |
| FY2008 | $3.84B | +10.2% | 10-K |
| FY2007 | $3.49B | - | 10-K |
Company: ELI LILLY & CoTicker: LLYSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →